TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization

por Thierry, Sylvain, Maadadi, Sarah, Berton, Aurore, Dimier, Laura, Perret, Clémence, Vey, Nelly, Ourfali, Saïd, Saccas, Mathilde, Caron, Solène, Boucard-Jourdin, Mathilde, Colombel, Marc, Werle, Bettina, Bonnin, Marc
Publicado 2023

HIRA Supports Hepatitis B Virus Minichromosome Establishment and Transcriptional Activity in Infected Hepatocytes

por Locatelli, Maëlle, Quivy, Jean-Pierre, Chapus, Fleur, Michelet, Maud, Fresquet, Judith, Maadadi, Sarah, Aberkane, Amel Neila, Diederichs, Audrey, Lucifora, Julie, Rivoire, Michel, Almouzni, Geneviève, Testoni, Barbara, Zoulim, Fabien
Publicado 2022

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes

por Lucifora, Julie, Bonnin, Marc, Aillot, Ludovic, Fusil, Floriane, Maadadi, Sarah, Dimier, Laura, Michelet, Maud, Floriot, Océane, Ollivier, Anaïs, Rivoire, Michel, Ait-Goughoulte, Malika, Daffis, Stéphane, Fletcher, Simon P., Salvetti, Anna, Cosset, François-Loïc, Zoulim, Fabien, Durantel, David
Publicado 2018